Adocia
About
History
Management
Board of directors
Advisory board
Products and platforms
Pipeline
Technology Platforms
Careers
The « Adocians »
HR policy
Work environment
Join us
Partnering
Investors
Media
Contact
Contact us
Map and accessibility
Investors
Regulated information
Stock information
Corporate governance
General meeting
Media
Press releases
Media
EN
FR
ADOCIA Reports Third Quarter 2025 Financial Results and Provides a Business Update
Previous article
ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in people with T1D
Next article
ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity – AdoXLong – and Provides an Update on its BioChaperone® Platform
